Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: A case-control study

Liver Transplantation

Volumn 13, Issue 5, 2007, Pages 665-671

  Dharancy, Sébastien ^a   Boitard, Jeanne ^a   Decaens, Thomas ^b   Sergent, Géraldine ^a   Boleslawski, Emmanuel ^a   Duvoux, Christophe ^b   Vanlemmens, Claire ^c   Meyer, Carole ^d   Gugenheim, Jean ^e   Durand, François ^f   Boillot, Olivier ^g   Declerck, Nicole ^a   Louvet, Alexandre ^a   Canva, Valérie ^a   Romano, Olivier ^a   Ernst, Olivier ^a   Mathurin, Philippe ^a   Pruvot, François René ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d HÔPITAL DE HAUTEPIERRE   (France)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^f BEAUJON HOSPITAL   (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CISPLATIN; CORTICOSTEROID; CYCLOSPORIN A; DOXORUBICIN; EPIRUBICIN; IODINATED POPPYSEED OIL; TACROLIMUS;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CASE CONTROL STUDY; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR NECROSIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NECROSIS; PREOPERATIVE CARE;

EID: 34249065201     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21109     Document Type: Article

References (29)

1. Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet 1998;351:214-5.
2. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139:817-23.
3. La Vecchia C, Lucchini F, Franceschi S, Negri E, Levi F. Trends in mortality from primary liver cancer in Europe. Eur J Cancer 2000;36:909-915.
4. Everhart JE, Lombardero M, Detre KM, Zetterman RK, Wiesner RH, Lake JR, et al. Increased waiting time for liver transplantation results in higher mortality. Transplantation 1997;64:1300-1306.
5. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:765-774.
6. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-701.
7. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004;240:900-909.
8. Castroagudin JF, Delgado M, Villanueva A, Bustamante M, Martinez J, Otero E, et al. Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates. Transplant Proc 2005;37:3871-3873.
9. Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 2005;11:1117-1126.
10. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002 18;359:1734-1739.
11. Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waitinglist and leads to excellent outcome. Liver Transpl 2003;9: 557-563.
12. Perez Saborido B, Meneu JC, Moreno E, Garcia I, Moreno A, Fundora Y. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg 2005;190:383-387.
13. Harnois DM, Steers J, Andrews JC, Rubin JC, Pitot HC, Burgart L, et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999;5:192-199.
14. Morino M, Miglietta C, Grosso M, De Giuli M, Bismuth H. Preoperative chemoembolization for hepatocellular carcinoma. J Surg Oncol Suppl 1993;3:91-93.
15. Spreafico C, Marchiano A, Regalia E, Frigerio LF, Garbagnati F, Andreola S, et al. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 1994;192:687-690.
16. Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, et al. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg 1995;1:242-248.
17. Oldhafer KJ, Chavan A, Fruhauf NR, Flemming P, Schlitt HJ, Kubicka. S, et al. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 1998;29:953-959.
18. Veltri A, Grosso M, Martina MC, Ciancio, A, David E, Salizzoni M, et al. Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study. Cardiovase Intervent Radiol 1998;21:393-398.
19. Roumilhac D, Sergent G, Pruvot FR, Talbodec N, Gamblez L, Ernst O, et al. Treatment of hepatocellular carcinoma: pathologic results after chemoembolization and liver transplantation. Transplant Proc 1999;31:416-417.
20. Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim. J, Durand F, et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005;11:767-775.
21. Mazzaferro V, Regalia E, Doci R, Andreola. S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
22. Group ALTS. A randomized prospective multiinstutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. In: Investigator Booklet and Protocol. 1998.
23. Ernst O, Sergent G, Mizrahi D, Delemazure O, Paris JC, L'Hermine C. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. AJR Am J Roentgenol 1999;172:59-64.
24. Di Bisceglie AM. Pretransplant treatments for hepatocellular carcinoma: do they improve outcomes? Liver Transpl 2005;11(Suppl 2):SlO-Sl3.
25. Majno, P, Giostra E, Morel P, Hadengue A, Mentha G. Management of hepatocellular carcinoma in the waiting list before liver transplantation. J Hepatol 2005; 42(Suppl):S134-S143.
26. Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005;100:2708-2716.
27. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30: 1434-1440.
28. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004;10:534-540.
29. Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997;25:1485-1489.